Page last updated: 2024-12-06

bromosuccinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bromosuccinic acid, also known as 2-bromobutane-1,4-dioic acid, is a dicarboxylic acid that exists as two enantiomers: (R)-bromosuccinic acid and (S)-bromosuccinic acid. It is a colorless solid that is soluble in water, ethanol, and ether. It is an important intermediate in the synthesis of other organic compounds. For example, it can be used to prepare succinic anhydride, which is a useful reagent in organic synthesis. Bromosuccinic acid can be synthesized by the bromination of succinic acid. It is a versatile compound that has been studied for its potential applications in a variety of fields, including medicine, agriculture, and materials science. It is also a valuable reagent for the synthesis of other organic compounds. Its importance lies in its ability to act as a starting material for the synthesis of various other compounds with diverse applications.'

bromosuccinic acid: RN given refers to undesignated isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bromosuccinic acid : A dicarboxylic acid that is succinic acid substituted at position 2 by a bromine atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID73557
CHEBI ID73712
SCHEMBL ID180137
MeSH IDM0104157

Synonyms (52)

Synonym
bromobutanedioic acid
nsc 227872
o3k54ibv7f ,
unii-o3k54ibv7f
einecs 213-087-7
ai3-52316
nsc227872
succinic acid, bromo-
nsc-227872
monobromosuccinic acid
2-bromobutanedioic acid
bromosuccinic acid
923-06-8
butanedioic acid, bromo-
bromosuccinic acid, 98%
inchi=1/c4h5bro4/c5-2(4(8)9)1-3(6)7/h2h,1h2,(h,6,7)(h,8,9)
qqwgvqwaeanrtk-uhfffaoysa-
2-bromosuccinic acid
A844190
(2s)-2-bromobutanedioate
dl-bromosuccinic acid
AKOS005208711
l-2-bromosuccinic acid, 4
bdbm85471
STL280260
FT-0633099
FT-0605206
CHEBI:73712
rs-bromosuccinic acid
(+-)-bromosuccinic acid
bromosuccinic acid, (+/-)-
butanedioic acid, 2-bromo-
bromosuccinic acid dl-form [mi]
bromosuccinic acid [mi]
SCHEMBL180137
2-bromo-2-deoxy-malic acid
W-100294
butanedioic acid, bromo-, (.+/-.)-
mfcd00153931
LMFA01090155
mfcd00004213
Q27144062
tetraisopropyl1,2-ethylenediphosphonate
bromosuccinicacid
DTXSID70870797
E78200
SB44933
SB45392
AS-76064
EN300-112307
SY063512
SY109366
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
dicarboxylic acidAny carboxylic acid containing two carboxy groups.
2-bromocarboxylic acidAny carboxylic acid in which the carbon bearing the carboxy group is substituted by a bromine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
proteolysisN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
protein deglycosylationN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activityN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
protein bindingN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
peptidase activityN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
extracellular spaceN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
lysosomeN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
endoplasmic reticulumN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
azurophil granule lumenN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
cytoplasmN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
lysosomeN(4)-(beta-N-acetylglucosaminyl)-L-asparaginaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1799666Inhibition Assay from Article 10.1080/14756360109162375: \\Glycosylasparaginase inhibition studies: competitive inhibitors, transition state mimics, noncompetitive inhibitors.\\2001Journal of enzyme inhibition, , Volume: 16, Issue:3
Glycosylasparaginase inhibition studies: competitive inhibitors, transition state mimics, noncompetitive inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.32 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index23.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (16.67%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]